Targeting IL-17A Improves the Dysmotility of the Small Intestine and Alleviates the Injury of the Interstitial Cells of Cajal during Sepsis

Figure 2

Motility of the small intestine in normal mice, septic mice treated with PBS, and septic mice treated with IL-17A-Ab. (a) Analysis of intestinal myoelectrical activity. The amplitude and frequency were compared among the groups 24 h and 48 h after CLP. (b) Analysis of intraluminal pressure. The intraluminal pressure of the small intestine was compared among the groups 24 h and 48 h after CLP (data are shown as the , to 6, ).

(a)

(b)